	US 11,998,578 B2
	Composition for use in the treatment and/or improvement of sleep and mood disorders
Marco Pane, Novara (IT); Angela Amoruso, Novara (IT); Mirta Fiorio, Novara (IT); Angela Marotta, Novara (IT); Giovanna Felis, Novara (IT); and Antonio Del Casale, Novara (IT)
Assigned to PROBIOTICAL S.P.A., Novara No (IT)
Filed by PROBIOTICAL S.P.A., Novara (IT)
Filed on Aug. 2, 2022, as Appl. No. 17/879,700.
Application 17/879,700 is a division of application No. 16/769,526, granted, now 11,458,176, previously published as PCT/IB2018/060362, filed on Dec. 19, 2018.
Claims priority of application No. 102017000146791 (IT), filed on Dec. 19, 2017.
Prior Publication US 2022/0362314 A1, Nov. 17, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/747 (2015.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 35/745 (2015.01); A61P 25/00 (2006.01)

CPC A61K 35/747 (2013.01) [A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 35/745 (2013.01); A61P 25/00 (2018.01)]

8 Claims

1. A composition comprising:

a mixture of bacteria strains, comprising:

(a) a bacterium strain of the Lactobacillus fermentum species identified as Lactobacillus fermentum LF16 DSM 26956,

(b) a bacterium strain of the Lactobacillus plantarum species identified as Lactobacillus plantarum LP01 LMG P-21021, and/or a bacterium strain of the Lactobacillus plantarum species identified as Lactobacillus plantarum LP02 LMG P-21020,

(c) a bacterium strain of the Lactobacillus rhamnosus species identified as Lactobacillus rhamnosus LR06 DSM 21981; and

(d) a bacterium strain of the Bifidobacterium longum species identified as Bifidobacterium longum BL04 DSM 23233.